go back

BCR-ABL1 Major Breakpoint Measurement

Delaware rates for HCPCS 0040U

Used in chronic myeloid leukemia to measure how much of the abnormal BCR-ABL1 gene fusion is present, which shows how the disease is responding. It reports a quantity for the major breakpoint form of the fusion only; a companion test covers both breakpoint forms.

Rates data updated July 2026.

Facilitymedian $468 · 10th–90th $468$4680%50%$468Professionalmedian $240 · 10th–90th $240$3390%50%90th$240$200.0$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$467.74
Median
$467.74
Typical High
$467.74
Aetna
Setting
Professional
Modifier
Global
Typical Low
$239.88
Median
$239.88
Typical High
$338.84
Cigna
Setting
Facility
Modifier
Global
Typical Low
$269.15
Median
$269.15
Typical High
$269.15
United
Setting
Professional
Modifier
Global
Typical Low
$173.78
Median
$245.47
Typical High
$616.60